NO IMPROVEMENT IN DETECTING CERVICAL CANCER WITH ADDITION OF HPV TEST IN CERVICAL SCREENING PROGRAMME IN THE UK


An article publicised Online First and in the July edition of The Lancet Oncology reports that the compounding of manlike papillomavirus (HPV) investigating with lawful liquid-based genetics (LBC) display does not meliorate the spotting of cervical cancer compared with LBC display alone. In the UK, liquid-based genetics (which is a liquefied modify of the Pap smudge test) has replaced the customary Pap smudge test.

Popularity: 9% [?]

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks

WP Text Ads Want visitors to your site? Buy an ad here.

Tags: , , ,

Related Post:

  • NATIONAL SURVEY SHOWS 70% OF WOMEN HAVE EXPERIENCED A SEXUAL HEALTH ISSUE
  • HPV TESTING SIGNIFICANTLY REDUCES DEATHS FROM CERVICAL CANCER, COMPARED TO OTHER METHODS INCLUDING PAP
  • OPINION PIECE EXAMINES SUPPORT SERVICES FOR WOMEN WHO ‘REFUSE TO ABORT’ FETUSES WITH GENETIC DEFECTS
  • MONTANA ABORTION-RIGHTS OPPONENTS RENEW ATTEMPTS AT ‘PERSONHOOD’ BALLOT INITIATIVE
  • CONFIRMATION OF HIGH EFFICACY OF HPV VACCINE AGAINST PRECANCEROUS CERVICAL LESIONS AND PROTECTIVE EFFECT OF VACCINATION PROGRAMS
  • ONTARIO WOMEN LIVE LONGER BUT DON’T PROSPER: STUDY
  • MAMMOGRAMS MAY IDENTIFY CANCERS THAT WOULD OTHERWISE JUST REGRESS
  • IN CALIFORNIA 1 IN 4 ADOLESCENT GIRLS HAS RECEIVED HPV VACCINE
  • NPR FEATURES DISCUSSION WITH PLANNED PARENTHOOD PRESIDENT ABOUT GIFT CERTIFICATE PROGRAM
  • NEW AUSTRALIAN STUDY: OVARIAN CANCER NOT A ‘SILENT KILLER’
  • Leave a Reply